We are live on ! Find out more
MMSI icon

Merit Medical Systems

93.53 USD
-0.67
0.71%
At close Updated Oct 27, 4:00 PM EDT
1 day
-0.71%
5 days
3.43%
1 month
7.51%
3 months
22.9%
6 months
38.71%
Year to date
8.19%
1 year
13.03%
5 years
36.58%
10 years
326.1%
 

About: Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.

Employees: 7,500

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 46.2%
Neutral 46.2%
Negative 7.7%
Negative
Seeking Alpha
8 hours ago
Conestoga Small Cap Composite Q3 2026 Portfolio Activity
The Conestoga Small Cap Composite returned -11.22% net of fees in 3Q26, trailing the -9.39% return for the Russell 2000 Growth Index. Small Cap Composite top 5 leaders include Repligen, Merit Medical, Stevanato Group, Descartes Systems and Digi International. Small Cap Composite bottom 5 laggards include Mercury Systems, AAON, RBC Bearings, SPX Technologies and UL Solutions.
Conestoga Small Cap Composite Q3 2026 Portfolio Activity
Positive
Zacks Investment Research
18 days ago
Cancer Stocks to Consider as Oncology Innovation Accelerates
Oncology stocks are gaining relevance as cancer care evolves, with Pfizer, Merit Medical Systems and Abbott advancing treatments, diagnostics and screening technologies.
Cancer Stocks to Consider as Oncology Innovation Accelerates
Neutral
GlobeNewsWire
21 days ago
Merit Medical Systems to Announce Third Quarter 2026 Results on October 29, 2026
SOUTH JORDAN, Utah, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today that it will release its financial results for the quarter ended September 30, 2026, after the close of the stock market on Thursday, October 29, 2026. Merit plans to hold its investor conference call on the same day (Thursday, October 29, 2026) at 4:30 p.m. Eastern (3:30 p.m. Central, 2:30 p.m. Mountain, and 1:30 p.m. Pacific).
Merit Medical Systems to Announce Third Quarter 2026 Results on October 29, 2026
Neutral
Zacks Investment Research
21 days ago
HSIC or MMSI: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Henry Schein (HSIC) or Merit Medical (MMSI). But which of these two stocks presents investors with the better value opportunity right now?
HSIC or MMSI: Which Is the Better Value Stock Right Now?
Neutral
Zacks Investment Research
21 days ago
Here's Why You Should Add Merit Medical Stock to Your Portfolio Now
MMSI's broad product portfolio, global expansion and strategic M&A support growth, while tariffs and China pressures remain key risks.
Here's Why You Should Add Merit Medical Stock to Your Portfolio Now
Positive
Zacks Investment Research
26 days ago
5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve
Here, we highlight five medical supplies stocks, MCK, CAH, BDX, MMSI and PDEX, with strong potential that investors should keep on their watchlist amid improving industry prospects.
5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve
Neutral
GlobeNewsWire
1 month ago
Merit Medical to Participate in Upcoming Investors Conferences in September
SOUTH JORDAN, Utah, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced that management is scheduled to participate in the following upcoming investor conferences:
Merit Medical to Participate in Upcoming Investors Conferences in September
Neutral
Zacks Investment Research
1 month ago
Here's Why You Should Add Merit Medical Stock to Your Portfolio Now
MMSI's broad portfolio, R&D investments and WRAPSODY opportunity support growth, while tariffs, China pressure and competition remain risks.
Here's Why You Should Add Merit Medical Stock to Your Portfolio Now
Neutral
Zacks Investment Research
2 months ago
Oncology Stocks to Add to Your Portfolio as Cancer Care Evolves
Oncology innovation is driving new treatment options, with Iovance, Merit Medical and Kura advancing cancer-focused therapies and technologies.
Oncology Stocks to Add to Your Portfolio as Cancer Care Evolves
Positive
Zacks Investment Research
2 months ago
Should You Buy MMSI as Growth Improves but Valuation Stays Elevated?
Merit Medical's growth case is strengthening as launches, acquisitions and therapeutic products broaden its mix, but its premium valuation raises the execution bar.
Should You Buy MMSI as Growth Improves but Valuation Stays Elevated?
Price charts implemented using Lightweight Charts™